PYROXD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.034600E-01
Normal-vs-Stage2
3.921000E-01
Normal-vs-Stage3
2.698300E-02
Normal-vs-Stage4
6.015200E-01
Stage1-vs-Stage2
8.855800E-01
Stage1-vs-Stage3
2.433400E-01
Stage1-vs-Stage4
3.804000E-01
Stage2-vs-Stage3
3.779200E-01
Stage2-vs-Stage4
3.462800E-01
Stage3-vs-Stage4
2.296400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.674800E-01
Normal-vs-AfricanAmerican
9.452600E-01
Normal-vs-Asian
3.250600E-01
Caucasian-vs-AfricanAmerican
3.633800E-01
Caucasian-vs-Asian
8.722000E-01
AfricanAmerican-vs-Asian
3.223000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.808200E-01
Normal-vs-Female
4.315400E-01
Male-vs-Female
5.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.192600E-01
Normal-vs-Age(41-60Yrs)
6.203400E-01
Normal-vs-Age(61-80Yrs)
4.198400E-01
Normal-vs-Age(81-100Yrs)
3.472800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.724400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.868000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.660400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.828590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.640200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.478600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.266000E-02
Normal-vs-Daily Drinker
8.401600E-01
Normal-vs-Weekly Drinker
1.466170E-01
Normal-vs-Occasional Drinker
4.694200E-01
Normal-vs-Social Drinker
2.091000E-01
Non Drinker-vs-Daily Drinker
3.349400E-01
Non Drinker-vs-Weekly Drinker
7.856600E-01
Non Drinker-vs-Occasional Drinker
5.124100E-02
Non Drinker-vs-Social Drinker
3.748200E-01
Daily Drinker-vs-Weekly Drinker
3.056600E-01
Daily Drinker-vs-Occasional Drinker
9.074200E-01
Daily Drinker-vs-Social Drinker
5.757600E-01
Weekly Drinker-vs-Occasional Drinker
9.118100E-02
Weekly Drinker-vs-Social Drinker
3.686400E-01
Occasional Drinker-vs-Social Drinker
3.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.714100E-02
Normal-vs-Grade 2
1.575920E-03
Normal-vs-Grade 3
1.423250E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.133750E-02
Grade 1-vs-Grade 3
4.896600E-01
Grade 1-vs-Grade 4
1.714100E-02
Grade 2-vs-Grade 3
1.794220E-01
Grade 2-vs-Grade 4
1.575920E-03
Grade 3-vs-Grade 4
1.423250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.176400E-02
Normal-vs-NonDiabetic
5.658800E-01
Diabetic-vs-NonDiabetic
3.359100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.259900E-02
Normal-vs-NoPancreatitis
4.242400E-01
Pancreatitis-vs-NoPancreatitis
3.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.138400E-01
Normal-vs-N1
4.047600E-01
N0-vs-N1
1.840970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.646200E-01
Normal-vs-TP53-NonMutant
8.844400E-01
TP53-Mutant-vs-TP53-NonMutant
8.584400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
